Design, synthesis, and biological evaluation of novel 3-oxo-2,3-dihydropyridazine derivatives as interleukin-2-inducible T-cell kinase (ITK) inhibitors
RSC Advances · 2025 · 15 (55) · 47565-47586
DOI: 10.1039/d5ra06565h ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Advances, 2025. Verfasst von Sudhakar Tangallapalli und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, School of Science, GITAM University Hyderabad 502102 Telangana India rgundla@gitam.edu +91-9849869933. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0). Gefördert von: Technology Agency of the Czech Republic, Gandhi Institute of Technology and Management, European Commission.
Abstract (Originalsprache)
This study reports the design, synthesis, and biological evaluation of a novel series of 3-oxo-2,3-dihydropyridazine derivatives for selective inhibition of ITK, with potential application in T-cell leukemia treatment.
Autor:innen und Institutionen
- Department of Chemistry, School of Science, GITAM University Hyderabad 502102 Telangana India rgundla@gitam.edu +91-9849869933.
- Aragen Life Sciences Ltd, Medicinal Chemistry Laboratory Division Hyderabad 500076 India.
- Institute of Molecular and Translational Medicine, Czech Advanced Technologies and Research Institute, Palacký University Olomouc Křížkovského 511/8 Olomouc 77900 Czech Republic.
- Institute of Molecular and Translational Medicine, Faculty of Medicine and Dentistry, Palacký University and University Hospital Olomouc Hněvotínská 1333/5 Olomouc 77900 Czech Republic viswanath.das@upol.cz +420 585 632…
- School of Chemistry & Physics, College of Agriculture, Engineering & Science, Westville Campus, University of KwaZulu-Natal P Bag X 54001 Durban 4000 South Africa KatariN@ukzn.ac.za +14093652520.
ORCID-Profile: Viswanath Das, Naresh Kumar Katari
Förderung
- Technology Agency of the Czech Republic
- Gandhi Institute of Technology and Management
- European Commission
- Ministerstvo Školství, Mládeže a Tělovýchovy
Zitieren
APA
Tangallapalli, S., Gundla, R., Paidikondala, K., Gurská, S., Rampeesa, N. K., Anugu, S. R., Džubák, P., Hajdúch, M., Das, V., & Katari, N. K. (2025). Design, synthesis, and biological evaluation of novel 3-oxo-2,3-dihydropyridazine derivatives as interleukin-2-inducible T-cell kinase (ITK) inhibitors. RSC Advances, 15(55), 47565-47586. https://doi.org/10.1039/d5ra06565h
Vancouver
Tangallapalli S, Gundla R, Paidikondala K, Gurská S, Rampeesa NK, Anugu SR, et al. Design, synthesis, and biological evaluation of novel 3-oxo-2,3-dihydropyridazine derivatives as interleukin-2-inducible T-cell kinase (ITK) inhibitors. RSC Advances. 2025;15(55):47565-47586. doi:10.1039/d5ra06565h
BibTeX
@article{Tangallapalli2025,
author = {Tangallapalli, Sudhakar and Gundla, Rambabu and Paidikondala, Kalyani and Gurská, Soňa and Rampeesa, Naveen Kumar and Anugu, Sreenivasa Reddy and Džubák, Petr and Hajdúch, Marián and Das, Viswanath and Katari, Naresh Kumar},
title = {Design, synthesis, and biological evaluation of novel 3-oxo-2,3-dihydropyridazine derivatives as interleukin-2-inducible T-cell kinase (ITK) inhibitors},
journal = {RSC Advances},
year = {2025},
volume = {15},
number = {55},
pages = {47565--47586},
doi = {10.1039/d5ra06565h}
}
EUVIMED